Related Experiment Video
Updated: Apr 14, 2026

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular
Shilpa Bhatia1, Nimrah A Baig2, Olga Timofeeva2
1Department of Radiation Oncology, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA.
Abstract:
The expression of members of the Eph family of receptor tyrosine kinases and their ephrin ligands is frequently dysregulated in medulloblastomas. We assessed the expression and functional role of EphB1 in medulloblastoma cell lines and engineered mouse models. mRNA and protein expression profiling showed expression of EphB1 receptor in the human medulloblastoma cell lines DAOY and UW228. EphB1 downregulation reduced cell growth and viability, decreased the expression of important cell cycle regulators, and increased the percentage of cells in G1 phase of the cell cycle. It also modulated the expression of proliferation, and cell survival markers. In addition, EphB1 knockdown in DAOY cells resulted in significant decrease in migration, which correlated with decreased β1-integrin expression and levels of phosphorylated Src. Furthermore, EphB1 knockdown enhanced cellular radiosensitization of medulloblastoma cells in culture and in a genetically engineered mouse medulloblastoma model. Using genetically engineered mouse models, we established that genetic loss of EphB1 resulted in a significant delay in tumor recurrence following irradiation compared to EphB1-expressing control tumors. Taken together, our findings establish that EphB1 plays a key role in medulloblastoma cell growth, viability, migration, and radiation sensitivity, making EphB1 a promising therapeutic target.
Insights
EphB1 receptor tyrosine kinase is dysregulated in medulloblastomas. Downregulating EphB1 inhibits tumor growth, migration, and enhances radiosensitivity, identifying it as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Eph family receptor tyrosine kinases and ephrin ligands are often dysregulated in medulloblastomas.
- EphB1's specific role in medulloblastoma pathogenesis and treatment response is not fully understood.
Purpose of the Study:
- To investigate the expression and functional significance of EphB1 in medulloblastoma.
- To evaluate EphB1 as a potential therapeutic target for medulloblastoma.
Main Methods:
- Assessed EphB1 mRNA and protein expression in medulloblastoma cell lines (DAOY, UW228).
- Utilized EphB1 knockdown and genetic loss models in cell lines and engineered mouse models.
- Analyzed effects on cell growth, viability, cell cycle, migration, and radiosensitivity.
Main Results:
- EphB1 is expressed in medulloblastoma cell lines.
- EphB1 downregulation reduced cell growth, viability, and migration, while increasing G1 cell cycle arrest.
- EphB1 knockdown enhanced radiosensitivity and delayed tumor recurrence in mouse models.
Conclusions:
- EphB1 plays a critical role in medulloblastoma progression and radiation response.
- Targeting EphB1 presents a promising therapeutic strategy for medulloblastoma treatment.
Related Concept Videos
Mitogens and the Cell Cycle
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Negative Regulator Molecules

